Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.
Read More…
Industry, Sector and Symbol
Industry Patent owners & lessors
Sub-IndustryElectronic Components
SectorConsumer Discretionary
Phone415-558-0200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.24 billion
Profitability
Miscellaneous
Employees2,193
Next Earnings Date1/29/2020 (Estimated)
OptionableOptionable
Dolby Laboratories (NYSE:DLB) Frequently Asked Questions
What is Dolby Laboratories' stock symbol?
Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."
How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?
Dolby Laboratories announced a quarterly dividend on Thursday, November 14th. Investors of record on Tuesday, November 26th will be given a dividend of $0.22 per share on Wednesday, December 4th. This represents a $0.88 annualized dividend and a yield of 1.30%. The ex-dividend date is Monday, November 25th. View Dolby Laboratories' Dividend History.
How were Dolby Laboratories' earnings last quarter?
Dolby Laboratories, Inc. (NYSE:DLB) issued its quarterly earnings results on Thursday, November, 14th. The electronics maker reported $0.43 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.48 by $0.05. The electronics maker earned $298.80 million during the quarter, compared to the consensus estimate of $297.55 million. Dolby Laboratories had a return on equity of 9.37% and a net margin of 20.56%. The firm's revenue was up 24.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.44 EPS. View Dolby Laboratories' Earnings History.
When is Dolby Laboratories' next earnings date?
What guidance has Dolby Laboratories issued on next quarter's earnings?
Dolby Laboratories issued an update on its FY 2020
After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of $3.40-3.50 for the period, compared to the Thomson Reuters consensus estimate of $2.87. The company issued revenue guidance of $$1.3-1.35 billion, compared to the consensus revenue estimate of $$1.35 billion.
What price target have analysts set for DLB?
5 brokerages have issued twelve-month target prices for Dolby Laboratories' stock. Their forecasts range from $73.00 to $85.00. On average, they expect Dolby Laboratories' share price to reach $79.00 in the next year. This suggests a possible upside of 16.6% from the stock's current price. View Analyst Price Targets for Dolby Laboratories.
What is the consensus analysts' recommendation for Dolby Laboratories?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dolby Laboratories.
What are Wall Street analysts saying about Dolby Laboratories stock?
Here are some recent quotes from research analysts about Dolby Laboratories stock:
- 1. According to Zacks Investment Research, "Dolby reported healthy fourth-quarter fiscal 2019 results with year-over-year increase in earnings and revenues. Impressive market traction of Dolby Cinema technology is proving to be a major profit churner for the company. It believes that surging demand for premium viewing experience will fuel growth for Dolby Cinema. Dolby’s growth strategy stands on three pillars, which includes advancing the science of sight and sound, providing creative solutions, and delivering superior experiences. However, escalating cost of sales has been a major concern. The company’s Products and Services segment is witnessing declining revenue trends due to soft China market, which is impairing its overall performance. Stiff competition, price-sensitive nature of the entertainment industry and fluctuations of cinema product sales remain other headwinds." (11/18/2019)
- 2. Barrington Research analysts commented, "We continue our OUTPERFORM investment rating on DLB and $85 price target: While the favorable financial impact from the rollout of new technologies continues to evolve, we feel the benefits from some of them are becoming increasingly meaningful. The company’s $0.76 annual dividend provides a yield of 1.2%. The company also is active in repurchasing its shares, with over $400 million in authorization currently remaining. Management has noted that monetization benefits from its cinema sector efforts remain in early stages in terms of financial metrics. However, excitement over the early success of these initiatives has created a more optimistic view of Dolby’s potential to create renewed corporate momentum as management continues to target a return to double-digit growth. Laboratories, Inc." (1/31/2019)
Has Dolby Laboratories been receiving favorable news coverage?
News headlines about DLB stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Dolby Laboratories earned a news impact score of 2.0 on InfoTrie's scale. They also assigned media stories about the electronics maker a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Dolby Laboratories.
Are investors shorting Dolby Laboratories?
Dolby Laboratories saw a decline in short interest in the month of November. As of November 15th, there was short interest totalling 893,300 shares, a decline of 8.0% from the October 31st total of 970,500 shares. Based on an average trading volume of 312,700 shares, the days-to-cover ratio is currently 2.9 days. Approximately 1.4% of the shares of the company are sold short. View Dolby Laboratories' Current Options Chain.
Who are some of Dolby Laboratories' key competitors?
What other stocks do shareholders of Dolby Laboratories own?
Who are Dolby Laboratories' key executives?
Dolby Laboratories' management team includes the folowing people:
- Mr. Kevin J. Yeaman, Pres, CEO & Director (Age 53)
- Mr. Lewis Chew, Principal Financial Officer (Age 56)
- Mr. Andy Sherman, Exec. VP, Gen. Counsel & Corp. Sec. (Age 52)
- Mr. Todd Pendleton, Sr. VP & Chief Marketing Officer (Age 47)
- Mr. Giles Baker, Sr. VP of Consumer Entertainment (Age 43)
Who are Dolby Laboratories' major shareholders?
Dolby Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Disciplined Growth Investors Inc. MN (1.75%), TimesSquare Capital Management LLC (1.19%), State Street Corp (0.86%), Marathon Asset Management LLP (0.64%), Sumitomo Mitsui Trust Holdings Inc. (0.48%) and Bradley Foster & Sargent Inc. CT (0.25%). Company insiders that own Dolby Laboratories stock include Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher, Ryan Nicholson and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.
Which major investors are selling Dolby Laboratories stock?
DLB stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, State Street Corp, Chartwell Investment Partners LLC, Marathon Asset Management LLP, Voya Investment Management LLC, Bradley Foster & Sargent Inc. CT, Stifel Financial Corp and Keeley Teton Advisors LLC. Company insiders that have sold Dolby Laboratories company stock in the last year include Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.
Which major investors are buying Dolby Laboratories stock?
DLB stock was acquired by a variety of institutional investors in the last quarter, including Disciplined Growth Investors Inc. MN, Trinity Street Asset Management LLP, First Trust Advisors LP, State of New Jersey Common Pension Fund D, Squarepoint Ops LLC, Parametric Portfolio Associates LLC, Sumitomo Mitsui Trust Holdings Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for Dolby Laboratories.
How do I buy shares of Dolby Laboratories?
Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Dolby Laboratories' stock price today?
One share of DLB stock can currently be purchased for approximately $67.76.
How big of a company is Dolby Laboratories?
Dolby Laboratories has a market capitalization of $6.79 billion and generates $1.24 billion in revenue each year. The electronics maker earns $255.15 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,193 workers across the globe.View Additional Information About Dolby Laboratories.
What is Dolby Laboratories' official website?
How can I contact Dolby Laboratories?
Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]
MarketBeat Community Rating for Dolby Laboratories (NYSE DLB)
MarketBeat's community ratings are surveys of what our community members think about Dolby Laboratories and other stocks. Vote "Outperform" if you believe DLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
